Omeprazole PELLETS 8.5%W/W: (OmeprazoleEnteric Coated pellets 8.5%w/w)
Product Description
Murli Krishna Pharma Pvt. Ltd.
-
IN
-
2016On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Primary activities
Murli Krishna Pharma Pvt. Ltd.
-
IN
-
2016On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from Murli Krishna Pharma Pvt. Ltd. (27)
-
Product TAMSULOSIN HCL SR PELLETS
Category - Alpha Blockers -
Product Venlafaxine ER Pellets
Venlafaxine is a selective serotonin nor epinephrine uptake inhibitor antidepressant which is used to treat major depressive disorder, anxiety and panic disorder. -
Product CLARITHROMYCIN MICRO PELLETS 27.5%W/W :(CLARITHROMYCIN Enteric Coated pellets 27.5%w/w)
Physical Specifications: White to off white spherical pellets, Pellets Size: ASTM 30#80. Release specification: As per latest USP std, including additional parameters i.e. Related Substances (RS/impurities) and Microbiological (Ready To Fill size 0 Capsule, for Hard Gelatin Capsule ... -
Product ITRACONAZOLE PELLETS 22% W/W:
ITRACONAZOLE PELLETS 22% W/W:
Specifications: White to off white spherical pellets,
Pellets Size: ASTM16#20:
Release specification: As per latest USP std.
Fill Weight:
For 100mg capsule: 455mg pellets filled in SIZE 0 capsules. 1 kg of Pellets can ... -
Product LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)
LANSOPRAZOLE Micro PELLETS 12.5%W/W: (Lansoprazole Enteric Coated Micro pellets 12.5%)
Physical Specifications: White to off while spherical pellets, Pellets Size: ASTM 30#50, ASTM 25#50
Release specification: As per latest USP std. including additional parameters i.e. ... -
Product Lansoprazole Pellets 8.5%
We Murli Krishna Pharma specialised in the manufacture of Pharmaceutical Pellets/ Micro Pellets / Granules and MUPS.We manufacture Lansoprazole Pellets 8.5%( Product complies to USP) Particle size: ( 14 #18), ( 16 #20) and ( 30 #80) Comparative Dissolution: The profile matches... -
Product Azithromycin Taste Masked Pellets
The objective of developing Azithromycin taste masked micro pellets (Multiple unit particulate system i.e. MUPS) by aqueous technology is to fill the micro pellets in to capsule, are compressed into tablet and also are constituted to make the oral suspension. -
Product Brinzolamide
MKPPL developed a Nano particle based matrix which can deliver hydrophilic as well as hydrophobic drugs using a combination of hydrophilic and hydrophobic excipients as a clear solution. This cogent use of excipients ensures that the drug is absorbed optimally and the Nano particles ensure that the dru... -
Product Budesonide
There is a potential for the development of inhalation medicines in lipid Nano particles to possess controlled release properties. MKPPL’s Budesonide suspension has been developed in a complete aqueous base using a couple of specialized solubilizers which also helps in the Nano encapsulation of the drug. -
Product Dexlansoprazole Pellets
The pharmaceutical form of dexlansoprazole is based on the unique technology of modified dual release. The active ingredient is released in two phases at different pH values and with a time interval. Consequently, the drug achieves two peak concentrations in the blood, and the total serum concentration... -
Product Duloxetine
The objective is to develop Duloxetine DR pellets by aqueous technology. Pellets developed by aqueous technology have advantage of avoiding the use of organic solvents -
Product Erlotinib MUPS, Granules
Murli Krishna Pharma developed a Nano particle based premix for direct compression into tablets. The premix was developed using the following approach: 1) Enhance the solubility of Erlotinib at near neutral pH. 2)  ...
Murli Krishna Pharma Pvt. Ltd. resources (6)
-
Brochure Corporate Brochure
Murli Krishna Pharma Pvt Ltd is a young and dynamic Novel Drug Delivery Systems (NDDS) organization that provides a range of effective solutions to optimize the delivery of pharmaceutical products. Our current activities include manufacturing of pre-finished formulations i.e. Pellets, Granules and MUPS using Aqueous Based technology, Nano Particles and Transdermal Oil.
-
Brochure Tamsulosin HCL SR Pellets 0.125%, 0.13%, 0.16%, 0.20%
Tamsulosin HCL SR pellets is developed using an Aqueous platform and our USP lies in complying with all the US Pharmacoepial specifications. With a formulation that is in line with the Innovator product in terms of release profile, We extensively use Extrusion spheronization process besides the wurster process -
Video Nab Paclitaxel (Albumin Bound)
Murli Krishna Pharma is one of the few companies from India who have developed Albumin bound Paclitaxel. The particle size and the encapsulation efficiency have matched with the innovator’s specifications. In Vitro Cell line studies have shown that the activity is comparable to the innovator. -
Video Orlistat Pellets 50%
Leading Manufacturer from India for Orlistat pellets. Offering a product matching the Innovator's release profile, our product does not infringe with the patent. -
Video Iron & Vitamin Liposomal Transdermal
A Topical administration route had been chosen for the first time for Iron and Vitamins. With Minimal to Zero side effects, the absorption is almost close to 60% when compared to that of the oral route where the absorption is less than 20%. With a strong back up of clinicals on infants, this product of Murli Krishna Pharma is in the process of getting patented
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance